Higher dopamine transporter density in Parkinson’s disease patients with depression

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Psychopharmacology

• Publication date

  2010-05-22

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1007/s00213-010-1867-yPMID 20495790
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Evaluation of patients with Clinically Unclear Parkinsonian Syndromes submitted to brain SPECT imaging using the technetium-99m labeled tracer TRODAT-1.

  2010cited by this paper
• Monoamine transporter availability in Parkinson’s disease patients with or without depression

  2009influential reference
• Striatal dopamine transporter imaging correlates with depressive symptoms and tower of London task performance in Parkinson's disease

  2008influential reference
• The accuracy of diagnosis of major depression in patients with Parkinson's disease: a comparative study among the UPDRS, the geriatric depression scale and the Beck depression inventory.

  2008cited by this paper
• Greater availability of dopamine transporters in patients with major depression--a dual-isotope SPECT study.

  2008influential reference
• Midbrain serotonin and striatum dopamine transporter binding in double depression: a one-year follow-up study.

  2008influential reference
• Can molecular imaging techniques identify biomarkers for neuropsychiatric disorders?

  2007cited by this paper
• Striatal dopaminergic activity (FDOPA‐PET) associated with cognitive items of a depression scale (MADRS) in Parkinson's disease

  2007influential reference
• Dopamine transporter binding in depressed patients with anhedonia.

  2006influential reference
• Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease.

  2005influential reference
• Depression in neurological disorders: Parkinson’s disease, multiple sclerosis, and stroke

  2005cited by this paper
• Dopamine transporter availability in medication free and in bupropion treated depression: a 99mTc-TRODAT-1 SPECT study.

  2005influential reference
• Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system.

  2005influential reference
• Greater availability of brain dopamine transporters in major depression shown by [99m Tc]TRODAT-1 SPECT imaging.

  2003influential reference
• Lower dopamine transporter binding potential in striatum during depression

  2001influential reference
• In vivo evidence for differential association of striatal dopamine and midbrain serotonin systems with neuropsychiatric symptoms in Parkinson's disease.

  2001influential reference
• Striatal dopamine transporter density in major depression

  1999influential reference
• The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.

  1999influential reference

• Role of the globus pallidus in motor and non-motor symptoms of Parkinson’s disease

  2024cites this paper
• Association of Hemispheric Asymmetry of Dopamine‐Transporter Binding with Risk of Parkinsonian Depression

  2024cites this paper
• Investigating affective neuropsychiatric symptoms in rodent models of Parkinson's disease.

  2024cites this paper
• Genetic Insights into the Molecular Pathophysiology of Depression in Parkinson’s Disease

  2023cites this paper
• Depression in Patients with Parkinson’s Disease: Current Understanding of its Neurobiology and Implications for Treatment

  2022cites this paper
• Longitudinal decline in striatal dopamine transporter binding in Parkinson’s disease: associations with apathy and anhedonia

  2022cites this paper
• Neuropsychiatric Symptoms in Parkinson’s Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden

  2022cites this paper
• The pathobiological basis of depression in Parkinson disease: challenges and outlooks

  2022cites this paper
• Neuropsychiatric symptoms and striatal monoamine availability in early Parkinson’s disease without dementia

  2020cites this paper
• Evaluation of dopamine transporter density in healthy Brazilians using Tc-99m TRODAT-1 SPECT

  2020cites this paper
• Management of psychiatric disorders in Parkinson’s disease

  2020cites this paper
• Drug Choices and Advancements for Managing Depression in Parkinson's Disease

  2020cites this paper
• Molecular Imaging of Depressive Disorders

  2020cites this paper
• PET and SPECT in Psychiatric Complications of Parkinson’s Disease

  2020cites this paper
• Psychiatric neuroimaging research in Brazil: historical overview, current challenges, and future opportunities

  2020cites this paper
• Virtual Rehabilitation in Parkinson Disease

  2020cites this paper
• SEMIQUANTITATIVE EVALUATION OF 99MTCTRODAT1 BINDING POTENTIAL BY TWO METHODS OF SPECT IMAGE RECONSTRUCTION.

  2019cites this paper
• The Neuropsychiatry of Parkinson Disease: A Perfect Storm.

  2019cites this paper
• Predicting neuropsychiatric symptoms of Parkinson’s disease with measures of striatal dopaminergic deficiency

  2019cites this paper
• Acute anxiety disorder, major depressive disorder, bipolar disorder and schizophrenia are related to different patterns of nigrostriatal and mesolimbic dopamine dysfunction

  2018cites this paper
• Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.

  2018cites this paper
• Interaction Between Neuropsychiatric Symptoms and Cognitive Performance in Parkinson’s Disease: What Do Clinical and Neuroimaging Studies Tell Us?

  2018cites this paper
• Lack of association between dopamine transporter loss and non-motor symptoms in patients with Parkinson’s disease: a detailed PET analysis of 12 striatal subregions

  2018cites this paper
• Abnormal ventral tegmental area‐anterior cingulate cortex connectivity in Parkinson’s disease with depression

  2018cites this paper
• Enhanced motivation of cognitive control in Parkinson's disease

  2018cites this paper
• Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson’s disease: evidence for dopaminergic basis?

  2017cites this paper
• Imaging behavioural complications of Parkinson’s disease

  2017cites this paper
• Dysphoria, dopaminergic medication and spatial memory in Parkinsons disease

  2017cites this paper
• Imaging the Etiology of Apathy, Anxiety, and Depression in Parkinson’s Disease: Implication for Treatment

  2017cites this paper
• Molecular imaging to track Parkinson's disease and atypical parkinsonisms: New imaging frontiers

  2017cites this paper
• Changes in neural circuitry associated with depression at pre-clinical, pre-motor and early motor phases of Parkinson's disease.

  2017cites this paper
• Effects of dopaminergic depletion and brain atrophy on neuropsychiatric symptoms in de novo Parkinson’s disease

  2017cites this paper
• Emotional manifestations of PD: Neurobiological basis

  2016cites this paper
• [Comorbid states in Parkinson's disease: an effect of MAO-B inhibitors].

  2016cites this paper
• Depression, anxiety, and apathy in Parkinson's disease: insights from neuroimaging studies

  2016cites this paper
• Loss of Dopamine Transporter Binding and Clinical Symptoms in Dementia With Lewy Bodies

  2016cites this paper
• Depression, Apathy, Anhedonia, and Fatigue in Parkinson’s Disease

  2015cites this paper
• Optimization of Imaging Parameters for SPECT scans of [99mTc]TRODAT-1 Using Taguchi Analysis

  2015cites this paper
• Mesolimbic dopaminergic dysfunction in Parkinson’s disease depression: evidence from a 123I-FP-CIT SPECT investigation

  2015cites this paper
• Die Echogenität der Substantia nigra in der transkraniellen Sonographie bei Patienten mit idiopathischem Parkinson-Syndrom

  2015cites this paper
• Optimization of Imaging Parameters for SPECT scans of ( 99m Tc)TRODAT-1 Using

  2015cites this paper
• Depressie bij de ziekte van Parkinson; de huidige stand van zaken

  2014cites this paper
• PET and SPECT in Psychiatric Complications of Parkinson's Disease

  2014cites this paper
• Depression and impulse control disorders in Parkinson's disease: two sides of the same coin?

  2014cites this paper
• Imaging of Dopamine and Serotonin Receptors and Transporters

  2014cites this paper
• Dopamine transporter imaging with [123I]FP-CIT (DaTSCAN) in Parkinson's disease with depressive symptoms: a biological marker for causal relationships?

  2013cites this paper
• Mesocortical dopaminergic dysfunction in Parkinson's disease-depression: Evidence from a 123I-FP-CIT SPECT investigation

  2013cites this paper
• Reduced Striatal Dopamine Synthesis Capacity is Associated with Symptoms of Depression in Patients with de novo Unmedicated Parkinson's Disease

  2013cites this paper
• Unraveling the Mechanisms Responsible for the Comorbidity between Metabolic Syndrome and Mental Health Disorders

  2013cites this paper
• Dopamine transporter shown by SPECT in patients with periodic leg movement after acute physical exercise.

  2013cites this paper
• Neuroimaging of depression in Parkinson's disease: a review

  2013cites this paper
• Affective disorders in Parkinson's disease.

  2013cites this paper
• Depressive symptoms in Parkinson's disease are related to reduced [123I]FP-CIT binding in the caudate nucleus

  2013cites this paper
• Dopamine transporter availability in heroin-dependent subjects and controls: longitudinal changes during abstinence and the effects of Jitai tablets treatment

  2013cites this paper
• Higher striatal dopamine transporter density in PTSD: an in vivo SPECT study with [99mTc]TRODAT-1

  2012cites this paper
• eview ey players in major and bipolar depression — A retrospective analysis of in vivo maging studies

  2012cites this paper
• Mild affective symptoms in de novo Parkinson's disease patients: relationship with dopaminergic dysfunction

  2012cites this paper
• Imaging correlates of apathy and depression in Parkinson's disease.

  2011cites this paper
• Increased dopamine transporter density in Parkinson's disease patients with Social Anxiety Disorder.

  2011cites this paper
• Reversible abnormal functional neuroimaging presentations in polycythemia vera with chorea

  2011influential citation
• Parkinson's disease: The quintessential neuropsychiatric disorder

  2011cites this paper
• Imaging dopamine transporters in Parkinson's disease.

  2010cites this paper